Kyverna Therapeutics, Inc. (KYTX) Tops Q3 EPS by 17c

Kyverna Therapeutics, Inc. (NASDAQ: KYTX) reported Q3 EPS of ($0.85), $0.17 better than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Kyverna Therapeutics, Inc. (KYTX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Target registers 15.5 million additional shares for employee incentive plan
• Zentek shares to move from Nasdaq to OTC Markets on Sept. 2